This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Dupont Nutrition Biosciences Aps. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Innovations of Jean-Philippe Obert
Introduction
Jean-Philippe Obert is an accomplished inventor based in Châtellerault, France. He has made significant contributions to the field of biotechnology, particularly in the area of coated dehydrated microorganisms. With a total of 2 patents to his name, Obert's work focuses on enhancing the stability and viability of microorganisms for various applications.
Latest Patents
Obert's latest patents include a groundbreaking invention related to coated dehydrated microorganisms. This invention involves a dehydrated microorganism surrounded by at least one coating, which comprises at least 25% of hygroscopic salt(s) by dry weight. The pH of the coating is designed to be compatible with the viability of the coated dehydrated microorganism. The coating can be partially crystalline, with the salt(s) having a crystallinity degree of up to 60% once applied. This innovation also encompasses liquid coating compositions, methods for coating and protecting dehydrated microorganisms, and methods for preparing food products, feed products, consumer healthcare products, or agri-products that contain such coated microorganisms.
Career Highlights
Throughout his career, Jean-Philippe Obert has worked with notable companies such as DuPont Nutrition Biosciences and Air Liquide. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Obert has collaborated with several professionals in his field, including Patrick Chaigneau and Geoffrey Babin. These collaborations have likely enriched his work and contributed to the development of his patents.
Conclusion
Jean-Philippe Obert is a notable inventor whose work on coated dehydrated microorganisms has the potential to impact various industries, including food and healthcare. His innovative approach and collaborations highlight his commitment to advancing biotechnology.